RFG - Bristol Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
905
-23
-2% -$23.5K 0.26% 76
2026
Q1
$853K Sell
928
-19
-2% -$19.3K 0.23% 79
2025
Q4
$1.02M Sell
947
-1,490
-61% -$1.42M 0.28% 71
2025
Q3
$1.86M Sell
2,437
-349
-13% -$260K 0.54% 44
2025
Q2
$2.17M Sell
2,786
-271
-9% -$211K 0.67% 34
2025
Q1
$2.52M Buy
3,057
+374
+14% +$311K 0.85% 28
2024
Q4
$2.07M Buy
+2,683
New +$2.22M 0.68% 30

Other funds holding LLY

RFG - Bristol Wealth Advisors's LLY Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $23.5K and leaving 905 shares worth $1.09M. The position accounts for 0.26% of the portfolio, ranked #76.

RFG - Bristol Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.52M in Q1 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • RFG - Bristol Wealth Advisors held 905 shares of Eli Lilly worth $1.09M as of Q2 2026.
  • RFG - Bristol Wealth Advisors sold 23 Eli Lilly shares in Q2 2026, an estimated $23.5K.
  • Eli Lilly made up 0.26% of RFG - Bristol Wealth Advisors's portfolio in Q2 2026, its #76 holding.
  • RFG - Bristol Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • RFG - Bristol Wealth Advisors's Eli Lilly position peaked at $2.52M in Q1 2025.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.